Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels

Endocrine

Volumn 46, Issue 2, 2014, Pages 241-248

  Su, Jian Bin ^a   Chen, Tong ^a   Xu, Feng ^a   Wang, Xue Qin ^a   Chen, Jin Feng ^a   Wu, Gang ^a   Jin, Yan ^a   Wang, Xiao Hua ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Continuous glucose monitoring; Glycemic variability; Normal glucose regulation; Oral disposition index

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; LIPID;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CELL FUNCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; MEAN BLOOD GLUCOSE; MEAN OF DAILY DIFFERENCE; METABOLIC PARAMETERS; ORAL DISPOSITION INDEX; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STANDARD DEVIATION OF BLOOD GLUCOSE; ANALYSIS; BLOOD; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84902356621     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0047-3     Document Type: Article

References (43)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S62-S69 (2011)
2. M.A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, R.A. Defronzo, Onehour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31, 1650-1655 (2008)
3. E. Succurro, M.A. Marini, F. Arturi, A. Grembiale, M. Lugarà, F. Andreozzi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti, Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207, 245-249 (2009)
4. E. Succurro, F. Arturi, M. Lugarà, A. Grembiale, T.V. Fiorentino, V. Caruso, F. Andreozzi, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti, One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin. J. Am. Soc. Nephrol. 5, 1922-1927 (2010)
5. F. Zaccardi, D. Pitocco, G. Ghirlanda, Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab. Res. Rev. 25, 199-207 (2009)
6. M. Brownlee, I.B. Hirsch, Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295, 1707-1708 (2006)
7. D.C. Klonoff, B. Buckingham, J.S. Christiansen, V.M. Montori, W.V. Tamborlane, R.A. Vigersky, H. Wolpert, Endocrine society, continuous glucose monitoring: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 2968-2979 (2011)
8. N. Mauras, L. Fox, K. Englert, R.W. Beck, Continuous glucose monitoring in type 1 diabetes. Endocrine 43, 41-50 (2013)
9. N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13, 921-928 (2011)
10. M.A. Abdul-Ghani, K. Williams, R. DeFronzo, M. Stern, Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29, 1613-1618 (2006)
11. M.A. Abdul-Ghani, D. Tripathy, R.A. DeFronzo, Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130-1139 (2006)
12. A. Festa, K. Williams, A.J. Hanley, S.M. Haffner, Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57, 1638-1644 (2008)
13. M.A. Abdul-Ghani, K. Williams, R.A. DeFronzo, M. Stern, What is the best predictor of future type 2 diabetes? Diabetes Care 30, 1544-1548 (2007)
14. M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-Järvinen, T. Van Haeften, W. Renn, J. Gerich, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295-301 (2000)
15. J.Y. Kim, D.K. Coletta, L.J. Mandarino, G.Q. Shaibi, Glucose response curve and type 2 diabetes risk in Latino adolescents. Diabetes Care 35, 1925-1930 (2012)
16. M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470 (1999)
17. R. Oka, K. Yagi, M. Sakurai, K. Nakamura, T. Moriuchi, S. Miyamoto, A. Nohara, M.A. Kawashiri, Y. Takeda, M. Yamagishi, Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr. J. 59, 55-64 (2012)
18. J. Zhou, W. Jia, Y. Bao, X. Ma, W. Lu, H. Li, C. Hu, K. Xiang, Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med. Sci. Monit. 14, CR552-CR558 (2008)
19. J. Zhou, H. Li, X. Ran, W. Yang, Q. Li, Y. Peng, Y. Li, X. Gao, X. Luan, W. Wang, W. Jia, Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med. Sci. Monit. 17, CR9-CR13 (2011)
20. L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.P. Cristol, C. Colette, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681-1687 (2006)
21. K.M. Utzschneider, R.L. Prigeon, M.V. Faulenbach, J. Tong, D.B. Carr, E.J. Boyko, D.L. Leonetti, M.J. McNeely, W.Y. Fujimoto, S.E. Kahn, Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32, 335-341 (2009)
22. R. Retnakaran, S. Shen, A.J. Hanley, V. Vuksan, J.K. Hamilton, B. Zinman, Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16, 1901-1907 (2008)
23. L. Monnier, C. Colette, D.R. Owens, Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J. Diabetes Sci. Technol. 2, 1094-1100 (2008)
24. D. Rodbard, New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol. Ther. 11, 551-565 (2009)
25. F. Moreau, M.A. Weiller, V. Rosner, L. Weiss, M. Hasselmann, M. Pinget, R. Kessler, L. Kessler, Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm. Metab. Res. 40, 502-506 (2008)
26. S.V. Madhu, S.K. Muduli, R. Avasthi, Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients. Diabetes Technol. Ther. 15, 461-465 (2013)
27. R. Borg, J.C. Kuenen, B. Carstensen, H. Zheng, D.M. Nathan, R.J. Heine, J. Nerup, K. Borch-Johnsen, D.R. Witte, ADAG Study Group, Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1Cderived average glucose (ADAG) study. Diabetologia 53, 1608-1611 (2010)
28. C. Wang, L. Lv, Y. Yang, D. Chen, G. Liu, L. Chen, Y. Song, L. He, X. Li, H. Tian, W. Jia, X. Ran, Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 76, 810-815 (2012)
29. A. Lapolla, A. Mosca, D. Fedele, The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr. Metab. Cardiovasc. Dis. 21, 467-475 (2011)
30. A. Sciacqua, R. Maio, S. Miceli, A. Pascale, G. Carullo, N. Grillo, F. Arturi, G. Sesti, F. Perticone, Association between onehour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One 7, e44470 (2012)
31. A. Sciacqua, S. Miceli, G. Carullo, L. Greco, E. Succurro, F. Arturi, G. Sesti, F. Perticone, One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34, 1406-1411 (2011)
32. A. Sciacqua, S. Miceli, L. Greco, F. Arturi, P. Naccarato, D. Mazzaferro, E.J. Tassone, L. Turano, F. Martino, G. Sesti, F. Perticone, One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34, 2291-2296 (2011)
33. N. Taheri, B. Iraj, M. Amini, P. Amini, A. Aminorroaya, Cardiovascular risk factors in relatives of type 2 diabetics with normal glucose tolerance test and elevated one-hour plasma glucose. Endokrynol. Pol. 61, 359-363 (2010)
34. K. Torimoto, Y. Okada, H. Mori, Y. Tanaka, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc. Diabetol. 12, 1 (2013)
35. M. Brownlee, Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820 (2001)
36. M. Brownlee, The pathophysiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625 (2005)
37. M.A. Marini, E. Succurro, S. Frontoni, S. Mastroianni, F. Arturi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti, Insulin sensitivity, b-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 35, 868-872 (2012)
38. M. Bergman, Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43, 504-513 (2013)
39. R.E. Pratley, C. Weyer, The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44, 929-945 (2001)
40. M. Fukushima, H. Suzuki, Y. Seino, Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res. Clin. Pract. 66, S37-S43 (2004)
41. S. Del Prato, Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia 46, M2-M8 (2003)
42. R.N. Bergman, M. Ader, K. Huecking, G. Van Citters, Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51, S212-S220 (2002)
43. K.D. Kohnert, P. Augstein, E. Zander, P. Heinke, K. Peterson, E.J. Freyse, R. Hovorka, E. Salzsieder, Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32, 1058-1062 (2009)